Education
About Us
Working with TipRanks
Follow Us
Vitasora Health (AU:VHL)
ASX:VHL
VHL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.10
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.10M
Market Cap
$37.81M
Enterprise ValueAU$59.15M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Mar 04, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,718,543,800
10 Day Avg. Volume694,010
30 Day Avg. Volume1,096,217
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.56
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Vitasora Health News
VHL FAQ
What was Vitasora Health’s price range in the past 12 months?
Vitasora Health lowest share price was AU$0.02 and its highest was AU$0.10 in the past 12 months.
What is Vitasora Health’s market cap?
Vitasora Health’s market cap is $37.81M.
When is Vitasora Health’s upcoming earnings report date?
Vitasora Health’s upcoming earnings report date is Mar 04, 2026 which is in 176 days.
How were Vitasora Health’s earnings last quarter?
Vitasora Health released its earnings results on Aug 27, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of -AU$0.002 by -AU$0.002.
Is Vitasora Health overvalued?
According to Wall Street analysts Vitasora Health’s price is currently Overvalued.
Does Vitasora Health pay dividends?
Vitasora Health does not currently pay dividends.
What is Vitasora Health’s EPS estimate?
Vitasora Health’s EPS estimate is >-0.01.
How many shares outstanding does Vitasora Health have?
Vitasora Health has 1,718,543,800 shares outstanding.
What happened to Vitasora Health’s price movement after its last earnings report?
Vitasora Health reported an EPS of -AU$0.004 in its last earnings report, missing expectations of -AU$0.002. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Vitasora Health?
Currently, no hedge funds are holding shares in AU:VHL
Vitasora Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:VHL Sentiment 80%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
420.00%
12-Months-Change
Fundamentals
Return on Equity
-114.43%
Trailing 12-Months
Asset Growth
191.71%
Trailing 12-Months
Company Description
Vitasora Health
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
Technical Analysis
Nova Eye Medical
―
Compumedics Limited
―
Impedimed Limited
―
Micro-X Ltd.
―
EMvision Medical Devices Ltd.
―
Options Prices
Currently, No data available
---